Details for Patent: 4,946,853

Summary for Patent: 4,946,853

Title:	Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
Abstract:	A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of nicotine to a solution of a solidifying or gel-forming agent or mixture thereon in a suitable solvent or mixture of solvents and mixing or heating the mixture thereby obtained so as to form the solid, semi-solid or mucilaginous medium. The preparation can be used in a method of treating withdrawal symptoms associated with smoking cessation and for combating the psychological dependence that occurs through frequency smoking.
Inventor(s):	Bannon; Yvonne B. (Naas, IE), Corish; John (Leopardstown, IE), Corrigan; Owen I. (Howth, IE), Geoghegan; Edward J. (Athlone, IE), Masterson; Joseph G. (Dublin, IE)
Assignee:	Elan Transdermal Limited (Athlone, IE)
Application Number:	07/188,226
Patent Claim Types: see list of patent claims	Formulation; Compound; Device; Use;

Drugs Protected by US Patent 4,946,853

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,946,853

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Ireland	1119/87	May 01, 1987
Ireland	1946/87	Jul 17, 1987

International Family Members for US Patent 4,946,853

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	161721
Australia	1534988
Australia	607214
Canada	1333051